5-10
2026
影响因子区间
—
平台估算
7%
2025
中国作者发文占比
—
收费
期刊简介:Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.
【译文】癌症免疫学研究期刊发表关于癌症免疫学重大进展的杰出原创文章,涵盖了从宿主-肿瘤相互作用的基础研究到模型系统中的开发治疗、患者早期转化研究和晚期临床试验的学科范围。该期刊向癌症研究界传播免疫学知识,催化跨学科工作,以加深对宿主-肿瘤关系的理解,更有效的癌症治疗和改善临床结果。论文经过严格审查,感兴趣的具体主题包括内源性抗肿瘤免疫、肿瘤促进性炎症、癌症抗原、疫苗、抗体、细胞疗法、细胞因子、免疫调节、免疫抑制、癌症治疗的免疫调节作用、新兴技术和临床研究。该期刊的特色功能包括“免疫学大师”——由领先的免疫学家撰写的入门指南,以及“癌症免疫学在十字路口”——强调免疫学与其他癌症研究领域和相关学科交叉的观点。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |